Evaluation of the effectiveness of topical gel (Cymbopogon schoenanthus and Anethum graveolens dhi) in osteoarthritis
Phase 2
Recruiting
- Conditions
- Knee Osteoarthritis.Osteoarthritis of knee
- Registration Number
- IRCT20221009056125N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients with knee Osteoarthritis Grade I and II
Exclusion Criteria
History of knee trauma
History of joint degenerative diseases (rheumatoid arthritis and ...)
History of fractures in and around the knee joint
History of knee joint infection
History of ligamental injury
BMI>30
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-inflammatory effects of Cymbopogon schoenanthus and Anethum graveolens in knee osteoarthritis?
How does the herbal topical gel IRCT20221009056125N1 compare to NSAIDs in managing knee osteoarthritis pain and function?
Are there specific biomarkers that predict response to Cymbopogon-Anethum graveolens gel in knee osteoarthritis patients?
What are the potential adverse events associated with Cymbopogon schoenanthus and Anethum graveolens topical application in phase II trials?
What combination therapies or competitor drugs show promise in knee osteoarthritis alongside Cymbopogon-Anethum graveolens gel?